Sodium chloride 0.372% solution, Dexamethasone sodium phosphate for encapsulation into autoerythrocytes
IEDAT-04-2022
Phase 3 small_molecule active
Quick answer
Sodium chloride 0.372% solution, Dexamethasone sodium phosphate for encapsulation into autoerythrocytes for Ataxia Telangiectasia is a Phase 3 program (small_molecule) at Quince Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Quince Therapeutics
- Indication
- Ataxia Telangiectasia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active